Board Appointment
Updated : 07:00
1 December 2021
ECO Animal Health Group plc
("ECO" or the "Company") (AIM: EAH)
Board Appointment
ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health market, is pleased to announce the appointment of Tracey James as a Non-Executive Director with immediate effect.
Tracey is a Chartered Accountant who has spent 26 years with Grant Thornton UK LLP, with the last 14 years as an Audit Partner. Tracey was a member of Grant Thornton's Oversight Board and also served on the Audit & Risk and Pensions Committees. She was also previously Finance Director of Karl Storz Endoscopy Canada (1999-2000). Tracey is currently a Non-Executive Director and Chair of the Audit Committee at specialist Engineering and Technology recruitment solutions business, Gattaca plc.
Tracey will join the Audit Committee of ECO.
Commenting on the appointment Andrew Jones, Chairman, said:
"I am delighted to welcome Tracey to the ECO Board. She has a strong financial background at senior level in Grant Thornton and brings with her a wealth of experience of growing businesses and AIM-listed companies."
Additional Information on the Board Appointment:
The following additional information is provided with regards to the appointment of Tracey Dawn James (née Clements), aged 58, in accordance with AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies:
Current directorships/partnerships:
Gattaca plc
Directorships/partnerships within the last five years:
Activate Learning Group (Charity)
Allenbuild Limited
Grant Thornton UK LLP
Millwood Designer Homes Limited
Modularwise Limited
Places for People Developments Limited
Places for People Group Limited
Places for People Ventures Limited
Places for People Ventures Operations Limited
Zeroc Group (2008) Limited
There are no further disclosures required to be made in respect of the appointment under AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.
Contacts:
ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO)
|
|
IFC Advisory Graham Herring Zach Cohen
| 020 3934 6630
|
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas
| 020 7496 3000 |
Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden
| 020 7418 8900 |
Equity Development Hannah Crowe Matt Evans
| 020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the Group") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.